Caution: The following texts are translated from the Japanese original. We cannot take responsibility for ambiguity in the translation.

Category 1 OTC medicine 

アラセナS ARASENA S

Product features

● Medicine for recurrent of oral herpes infection containing vidarabine, an anti-herpesvirus component.
● It is recommended to apply it immediately when you notice any discomfort such as tingling or irritation on or around your lips.

Indication

Recurrence of oral herpes infection (limited to those who have been diagnosed and treated by a doctor in the past)

Dosage and administration

Apply topically an appropriate amount to the affected lesion 1 to 4 times a day.
(Apply immediately if you notice any discomfort such as tingling or irritation on or around your lips.)
・ If you use it early, it will heal quickly and will not get worse, so start using it as soon as possible (within 5 days) if you notice any discomfort such as tingling or irritation.
・ Use after meals and before going to bed.

Precautions of Dosage and Administration

(1)Strictly follow the prescribed dosage and administration.
(2)When allowing children to use the medicine, a guardian must be present to watch and tell such them how to use it.
(3)Attention should be paid so that the medicine will not come into contact with eyes. If the medicine comes into contact with eyes, immediately rinse them with water or lukewarm water. If the symptoms are severe, seek an ophthalmologist for medical treatment.
(4)This medication is only for external use.
(5) Do not put in your mouth or lick.
(6) Please be careful not to accidentally allow use by a family member who has developed symptoms for the first time.

Ingredient and amount

In 1g
Vidarabine:30mg:Suppresses the growth of herpes virus.

Precautions

■When not to use the product
(If you do not follow these instructions, the current symptoms may worsen or adverse reactions/incidents are more likely to occur.)
1.This product should not be used by the following persons
(1)Persons who have not received diagnosis with or treatment for oral herpes infection by doctor.
(Persons who have never been diagnosed with oral herpes infection by a doctor are difficult to judge for the condition by themselves, and if they first develop, symptoms may be worse, so see a doctor.)
(2) Individuals with extensive affected area. (If the affected area covers a wide area, it is a serious case. You should consult a doctor.)
(3)Patients who have had an allergic symptom to this drug or its ingredients. (The use of this medicine may cause allergic symptoms again.)
(4)Infants and toddlers under 6 years old.(Infants are likely to be infected for the first time.)
(5)Persons with systemic symptoms such as fever and widespread rash. (If systemic symptoms such as fever or widespread rash are present, it may become severe, so please consult a doctor.)

2.Do not use on areas other than the lips and around the lips.
(Oral herpes infection occurs in and around the lips.)
3.Do not take this medicine for a long time
(Even if symptoms improve with the use of this drug, if it takes more than 2 weeks to heal, it may be a severe case or another disease.)

■Consultation
1.The following persons should consult a physician or pharmacist before use.
(1)Patients undergoing medical treatment from a physician(Other drugs prescribed by your physician may be affected, or you may already be using the same medicine as this drug.)
(2)Pregnant women or women suspected of being pregnant.(Care should be taken when using the drug, and you should consult a specialist for instructions.)
(3)Nursing women.(Transition to milk has been confirmed when animals are injected with the same ingredients as this drug.)
(4)Patients who have experienced allergic symptoms associated with drugs, etc. (People who have allergies due to drugs, etc. may exprience allergic symptoms with this drug.)
(5)Those with severe moistening or erosion. (You may have severe oral herpes infection or other diseases, so you should consult a specialist for instructions.)
(6)People with atopic dermatitis. (Since it may become severe, it is necessary to consult a specialist for instructions.)
2.If the following symptoms are observed after using this drug, these may be adverse reactions, so immediately discontinue the use, and show this document to your physician or pharmacist for a consultation.

Skin: rash/redness, swelling, itching, rash, irritation
(It is considered to be allergic symptom by this medicine or stimulation by this medicine. In such a case, symptoms may worsen if you continue using.)
3.If symptoms do not improve after taking for 5 days, stop taking and consult your doctor or pharmacist with this document.
(If symptoms do not improve after 5 days of use, it may be a severe case or another disease, so please consult your doctor or pharmacist as soon as possible.)

Additive

Vaseline, liquid paraffin

Precautions for storage and handling

(1)Keep tightly sealed in a cool place of 30°C or less with low humidity and no direct sunlight.
(2)Keep out of reach of children.
(3)Wash hands before and after use.
(4)Do not transfer the medicine to a different container. (It may lead to misuse or alter the quality of the drug. )
(5)Do not take (use)the product after its expiration date. Even within the expiration date, use within 6 months after opening.(When using after opening, wipe off the oil at the end of the tube before use.)

Disclaimer on Multilingual Product Information

・This product is a pharmaceutical product approved under a Japanese law, the Law for Ensuring the Quality, Efficacy and Safety of Drugs and Medical Devices, with a view to its sale and use in Japan.

・Multilingual product information is a translation of the product labeling written in Japanese and provided for your information only. It does not warrant that its contents and the product itself conforms to laws and regulations in countries other than Japan.

・Multilingual product information is a tentative translation by Our Company, and may be modified or altered without notice.

・Our Company assumes no responsibility for any occurred problem attributable to the contents of the multilingual product information.